The Expanding Role of Patient Support Programs in Pharmaceutical Markets

Developing innovative therapies remains central to pharmaceutical care, but supporting patients throughout their treatment journey has become equally important. As therapies become more specialized and treatment pathways more complex, many patients require ongoing support beyond diagnosis and prescription. This has brought greater attention to Patient Support Programs (PSPs), which are becoming an increasingly important part of pharmaceutical care. As these programs continue to evolve alongside changing patient needs and healthcare delivery models, understanding the factors that shape effective Patient Support Programs has become an important focus of pharma market research. In this article, we’ll explore the expanding role of Patient Support Programs and the growing importance of research in shaping them.

What are Patient Support Programs?

Patient Support Programs (PSPs) are structured, non-promotional services designed to help patients navigate different stages of their prescribed treatment. They complement clinical care by supporting patients before, during, and throughout therapy while healthcare professionals continue to make all clinical decisions. Depending on the program and local regulations, PSPs are typically delivered by pharmaceutical companies through specialized service providers in collaboration with healthcare professionals.

Patient Support Programs are sometimes confused with patient assistance programs, but the two serve different purposes. Patient assistance programs primarily focus on improving access to medications, while Patient Support Programs take a broader approach by supporting patients throughout their treatment journey. The type of support varies by therapy, disease area, and individual patient needs, making these programs far more personalized than a one-size-fits-all model.

Depending on the therapy area and patient needs, Patient Support Programs commonly include:

• Patient education and disease awareness
• Therapy onboarding and treatment initiation support
• Adherence and persistence support
• Reimbursement or access navigation, where applicable
• Nurse educator or care coordination support
• Digital tools for reminders, education, and ongoing engagement

For example, a patient starting a biologic therapy for an autoimmune condition often requires support beyond receiving a prescription. Questions about self-administering the treatment, understanding what to expect during therapy, and staying on track with a long-term treatment plan can arise throughout the care journey. A Patient Support Program helps address these practical, non-clinical needs through structured education and ongoing support while healthcare professionals continue to oversee all medical decisions.

Read Also: The Sales Head: Conducting Research with Star KOLs in the Pharmaceutical Industry

The Growing Importance of Patient Support Programs

Patient Support Programs have become an integral part of pharmaceutical care as the way therapies are developed, delivered, and managed has changed. Several factors have contributed to this evolution, including:

• More complex therapies: The growing use of biologics, specialty medicines, gene therapies, and other advanced treatments has created a greater need for patient education and practical support throughout treatment.
• Longer treatment journeys: Many therapies involve treatment initiation, self-administration, ongoing monitoring, and long-term disease management, making support necessary well beyond prescription.
• Healthcare extending beyond hospitals and clinics: Home-based care, telehealth, and remote monitoring have shifted many aspects of treatment into patients’ everyday lives, creating new support requirements outside traditional clinical settings.
• A stronger emphasis on the overall treatment journey: Pharmaceutical companies now recognize that helping patients obtain treatment is only one part of the care journey. Supporting therapy initiation, continuation, and day-to-day treatment experiences has become equally important.

Designing Patient Support Programs Around Patient Needs

Patient Support Programs must be tailored to address the specific barriers patients face when accessing and adhering to treatment.

Several factors influence how a Patient Support Program is designed, including:

• Therapy-specific support requirements: Even within the same disease area, different therapies create different support needs. For example, an oral medication, a self-injectable biologic, and a gene therapy each require different levels of education, training, and ongoing support.
• Changing needs throughout treatment: The support patients need before starting therapy often differs from what they need after treatment begins or during long-term disease management. Programs should adapt to these changing needs instead of providing the same support at every stage.
• Differences across patient populations: Age, health literacy, digital literacy, previous treatment experience, and caregiver availability all influence how patients engage with treatment and the type of support they find most valuable.
• Multiple stakeholder perspectives: Patients, caregivers, physicians, nurses, and other healthcare professionals each interact with treatment differently. Considering these perspectives helps ensure that support programs fit naturally into both patient experiences and routine clinical care.
• Healthcare systems and local care pathways: Access processes, reimbursement models, regulations, and care delivery vary across countries and healthcare systems. Programs often require local adaptation rather than a standardized global approach.

The Growing Role of Pharma Market Research in Patient Support Programs

Designing an effective Patient Support Program begins with understanding the people it is intended to support. Rather than relying on assumptions, pharma market research helps organizations gather evidence that informs program planning, implementation, and ongoing refinement throughout the patient support journey.

Understanding Patient Needs Before Program Design

Before a program is developed, pharma market research helps organizations build a clear understanding of:

• Unmet patient needs
• Patient journey mapping
• Therapy-specific challenges
• Treatment barriers
• Caregiver experiences
• Preferred support services
• Communication preferences

Aligning Patient Support With Clinical Practice

A Patient Support Program should support both patients and the healthcare professionals involved in delivering care. Research helps organizations understand:

• Physician expectations
• Clinical workflow integration
• Care pathway considerations
• Healthcare professional perspectives
• KOLs in the pharmaceutical industry
• Alignment between patient and clinician needs

Refining Patient Support Programs Over Time

Patient needs and healthcare delivery continue to evolve after a program is introduced. Ongoing research helps organizations evaluate:

• Patient satisfaction
• Program participation
• Support service utilization
• Patient engagement
• Reasons for discontinuation
• Emerging support needs
• Opportunities for continuous improvement

Read Also: 5 Strategies for Successfully Engaging KOLs in Pharma Market Research

Rather than simply measuring enrollment, market research in the pharmaceutical industry helps organizations understand how Patient Support Programs perform in real-world settings and identify opportunities to strengthen the patient experience over time.

How Unimrkt Healthcare Supports Patient Support Program Research

Effective Patient Support Programs depend on a clear understanding of patient experiences, stakeholder perspectives, and therapy-specific challenges. Unimrkt Healthcare supports pharmaceutical and life sciences organizations by conducting primary research that collects reliable data to support planning, implementation, and refinement of Patient Support Programs throughout the product lifecycle.

Our capabilities include:

• Patient and stakeholder research: Engaging patients, caregivers, healthcare professionals, payers, and other stakeholders to understand treatment experiences, support needs, communication preferences, and factors shaping Patient Support Programs across different therapy areas.
• Research across diverse therapeutic areas: Conducting studies across specialty medicines, biologics, generics, biosimilars, over-the-counter products, and a broad range of therapeutic categories, recognizing that Patient Support Programs often require therapy-specific research and stakeholder engagement.
• End-to-end primary research execution: Supporting every stage of the research process, including study design, questionnaire development, respondent recruitment, fieldwork management, data collection, and data processing to collect reliable primary data for Patient Support Programs.
• Qualitative and quantitative research: Conducting in-depth interviews, focus group discussions, surveys, and other primary research studies to collect stakeholder perspectives before program development, during implementation, and throughout ongoing program refinement.
• Global research capabilities: Executing multi-country and multi-market studies through an extensive international network, helping organizations collect consistent primary data across diverse healthcare systems and patient populations.

With extensive experience in life sciences market research, Unimrkt Healthcare supports pharmaceutical organizations in generating reliable primary data to support planning, implementation, and continuous refinement of Patient Support Programs throughout the product lifecycle.

About Unimrkt Healthcare

Unimrkt Healthcare is a specialized healthcare-focused market research company supporting organizations across pharmaceuticals, medical devices, digital health, healthcare providers, healthcare payers, and animal healthcare. Through structured primary research, we engage patients, physicians, payers, administrators, KOLs in the pharmaceutical industry, and other healthcare stakeholders to collect reliable data across diverse healthcare markets and research objectives.

Our expertise spans qualitative and quantitative research, healthcare stakeholder engagement, and end-to-end research execution. Supported by global research capabilities across 90+ countries and 22+ languages, our processes are aligned with internationally recognized standards, including ISO 20252 and ISO 27001, supporting quality, data security, privacy, and compliance throughout every study. To learn more about our healthcare research capabilities, contact us at +91-124-424-5210 or +91-9870-377-557, email sales@unimrkthealth.com, or fill out the contact form on our website, and our team will connect with you promptly.

Frequently Asked Questions

1. How do pharmaceutical companies determine whether patients need a Patient Support Program?

Pharmaceutical companies determine the need for a Patient Support Program by identifying challenges patients experience throughout treatment. Primary research helps uncover unmet needs, therapy-specific barriers, adherence challenges, caregiver requirements, and support preferences before a program is developed.

2. When should a Patient Support Program be introduced during a product’s lifecycle?

Patient Support Programs are ideally planned before product launch so patient and stakeholder needs can be incorporated early. They continue to evolve after launch as organizations collect data on patient experiences, program utilization, and changing treatment needs.

3. How does pharma market research support the development of Patient Support Programs?

Pharma market research collects data on patient experiences, healthcare professional expectations, treatment barriers, and support preferences. This information helps organizations design Patient Support Programs that reflect real-world needs rather than assumptions.

4. What role do caregivers play in Patient Support Programs?

Caregivers often help patients manage medications, coordinate appointments, monitor treatment, and provide day-to-day support. Their perspectives are particularly important in pediatric care, rare diseases, neurodegenerative disorders, and other therapies where patients require ongoing assistance.

5. How do pharma companies adapt Patient Support Programs globally?

Pharma companies adapt Patient Support Programs by considering differences in healthcare systems, reimbursement pathways, regulations, and patient expectations across countries. At Unimrkt Healthcare, we conduct multi-country primary research to help organizations collect local stakeholder perspectives before implementing programs across diverse markets.

6. What should organizations look for when choosing a pharma market research company for Patient Support Program research?

Organizations should look for healthcare research expertise, access to relevant stakeholder groups, experience across therapeutic areas, and the ability to execute multi-market studies. At Unimrkt Healthcare, we conduct qualitative and quantitative primary research that supports Patient Support Programs throughout planning, implementation, and ongoing refinement.